SINGAPORE, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Rectitude Holdings Ltd. (Nasdaq: RECT; the “Company” or “Rectitude”), a Singapore-based provider of safety equipment and related industrial products, today announced that it is initiating a Bitcoin treasury strategy via entering into a Standby Equity Purchase Agreement (the “SEPA”) with Constantinople Limited, a British Virgin Islands Company led by Tian Jia, an experienced Bitcoin investor, as Lead Investor, and Chen Zhiqiang, former co-founder and CTO of Tron, ...

Core Viewpoint - Mohist AI Limited has launched TranGPT, a multilingual AI-powered translation and text-to-speech SaaS platform aimed at enhancing communication for e-commerce sellers, financial professionals, and global enterprises [1][11]. Group 1: Product Features - TranGPT combines neural machine translation with advanced text-to-speech technology, enabling real-time communication across languages, particularly in business-critical scenarios like customer service and financial communication [3][14]. - The platform supports over 30 global languages, including English, Chinese, Japanese, Korean, Turkish, and Thai, allowing users to connect with customers in their native languages [7]. - TranGPT offers real-time AI translation, facilitating instant responses from support teams and financial staff, which leads to faster resolutions and smoother collaboration [8]. - The text-to-speech feature provides natural, human-like voices, enhancing customer experience in call centers and automated support [9]. - The platform operates under Hong Kong jurisdiction, ensuring enterprise-grade security and compliance with data privacy regulations [10]. Group 2: Market Relevance - The growth of cross-border trade, particularly in e-commerce and financial services, highlights the need for effective communication tools, as 70% of buyers are more likely to purchase when addressed in their native language [5]. - TranGPT addresses the language barrier challenge, providing a professional-grade AI tool that ensures accuracy and cultural sensitivity [5]. Group 3: Future Developments - Upcoming enhancements for TranGPT include AI-based voice cloning for personalized communication, multi-channel API integration for seamless workflow, and real-time risk management tools tailored for financial professionals [12][13]. - The company is committed to continuous innovation based on user feedback, aiming to expand TranGPT's capabilities and global reach [11].

SALT LAKE CITY, Utah, Sept. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics innovator specializing in biomedical applications of silicon nitride (Si₃N₄), today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 1,099,431 shares of common stock of the Company originally issued in February 2025, having an exercise price of $3.32 per share. The shares of ...

MELBOURNE, Australia and SAN FRANCISCO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced it has received binding commitments for a capital raising of A$20.0 million (the “Placement”) of fully paid ordinary shares (“New Shares”) to International and Australian professional investors. "We are thankful for the continued inte ...

New Massive Sulphide Mineralization FoundTORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Sparton Resources Inc. (TSXV-SRI) ("Sparton" or the "Company”) announced today that field operations are underway at the Pense Critical Metals Project near Englehart in Northern Ontario and Quebec. The Pense mineralization exhibits many similarities to the world-class Outokumpu deposits in Finland. Results of the initial drill program and Ontario Junior Exploration Program (“OJEP”) funding assistance at Pense on the Ontario ...

SASKATOON, Saskatchewan, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce the signing of a definitive share purchase agreement to acquire a 100% interest in a PharmaChoice Canada bannered pharmacy business located in Ontario (the “Acquisition”). This transaction marks PharmaCorp’s first acquisition under its charter company structure, which was established through the purchase completed on April 30, 2025. In addition, PharmaCorp ha ...

Phase 3 trial to evaluate two subcutaneous BRIUMVI dosing regimensNEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has commenced in a Phase 3 trial evaluating subcutaneous BRIUMVI (ublituximab-xiiy), the company’s anti-CD20 monoclonal antibody, in people with relapsing forms of multiple sclerosis (RMS). BRIUMVI is currently approved in the United States, as well as several ex-US territories, as a one-hour intravenous (IV) infusion administere ...

TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”) today announced its Xtract One Gateway (“Gateway”) system has been selected by Delmar School District in Delmar, Delaware to strengthen protection of its middle and high school building entrances, with system installation set for the fall semester. In selecting Xtract One, Delmar School District is fostering a secure and welcoming experience for students, staff, and visit ...

– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES –Vancouver, BC & Edinburgh, Scotland, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, is pleased to announce that it has made its first strategic software investment into RideScan Ltd ( ...

WASHINGTON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Shaun Rangappa, MD, MSHA, as a Senior Managing Director in the Healthcare Business Transformation practice within the firm’s Corporate Finance & Restructuring segment. A graduate of the University of Virginia School of Medicine, Dr. Rangappa brings over 30 years of experience in healthcare, spanning clinical practice, clinical process evaluation and performance improvement, technology enablemen ...